KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Cash from Financing Activities (2019 - 2025)

Clover Health Investments' Cash from Financing Activities history spans 7 years, with the latest figure at -$8.6 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 40.16% year-over-year to -$8.6 million; the TTM value through Dec 2025 reached -$53.4 million, down 207.49%, while the annual FY2025 figure was -$53.4 million, 207.49% down from the prior year.
  • Cash from Financing Activities reached -$8.6 million in Q4 2025 per CLOV's latest filing, down from -$5.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $662.5 million in Q1 2021 to a low of -$31.7 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is $42.2 million, with a median of -$2.7 million recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: soared 151356.62% in 2021, then tumbled 2073.47% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $284.4 million in 2021, then plummeted by 99.98% to $56000.0 in 2022, then crashed by 1575.0% to -$826000.0 in 2023, then plummeted by 643.46% to -$6.1 million in 2024, then crashed by 40.16% to -$8.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Cash from Financing Activities are -$8.6 million (Q4 2025), -$5.3 million (Q3 2025), and -$7.8 million (Q2 2025).